Low-Level Laser Therapy (LLLT / LASMIK®) in Supportive Oncology Care
- Maria Sazhina
- Dec 12, 2025
- 2 min read
Updated: Dec 20, 2025
Low-Level Laser Therapy (LLLT), including the clinically applied LASMIK® laser therapy method, is a non-invasive, physiotherapeutic approach widely used in oncology as supportive and rehabilitative care.It is designed to help patients better tolerate standard oncological treatments, reduce therapy-related complications, and improve overall quality of life throughout all stages of care.
LASMIK® therapy is painless, does not involve systemic drug exposure, and can be safely integrated into multidisciplinary oncology protocols under medical supervision.
Main Indications for LASMIK® Laser Therapy in Oncology
In cancer patients, LASMIK® laser therapy may be used for the following supportive indications:
• Reduction of psychosomatic and neurovegetative stress
Helps stabilize the nervous system, reduce anxiety, and improve adaptive stress responses during intensive treatment periods.
• Relief of acute and chronic pain
Supports management of postoperative pain, soft-tissue inflammation, musculoskeletal discomfort, and chronic pain syndromes.
• Immunomodulatory support
Assists in maintaining immune balance during chemotherapy, radiation therapy, and recovery phases.
• Stimulation of endogenous detoxification mechanisms
Supports cellular metabolism, microcirculation, and natural detoxification pathways during antineoplastic drug therapy.
• Prevention and management of postoperative inflammatory complications
Improves tissue regeneration, reduces edema, and supports wound healing after oncological surgery.
• Support during chemotherapy
May help reduce the severity of toxic reactions, improve mucosal integrity, and enhance overall treatment tolerance.
• Management of early radiation reactions
Used to support healing of irradiated tissues and help mitigate early skin and mucosal radiation damage.
• Adjunct support during chemoradiation therapy
Enhances tissue resilience and functional recovery when used alongside standard protocols.
• Rehabilitation and treatment of concomitant chronic conditions
Supports patients during rehabilitation stages by addressing comorbid inflammatory, pain-related, and functional disorders.
LASMIK® Therapy at All Stages of Oncology Care
Laser therapy using the LASMIK® method can be applied at nearly every stage of oncological care as part of a comprehensive supportive program:
Preoperative stage (2–3 days before scheduled surgery)
To help prepare tissues, regulate inflammation, and reduce the risk of postoperative complications.
During chemotherapy
To support tolerance of systemic therapy and reduce treatment-related side effects.
During radiation and combined chemoradiation therapy
To assist in managing early radiation reactions and improve tissue recovery.
Rehabilitation and recovery stages
To support pain control, immune balance, functional restoration, and overall wellbeing.
LASMIK® therapy does not replace oncological treatment, but complements it by addressing supportive and rehabilitative needs.
Key Advantages of LASMIK® Laser Therapy
Non-invasive and painless
No systemic pharmacological effects
Short, comfortable treatment sessions
Compatible with surgery, chemotherapy, and radiation therapy
Focused on symptom relief, recovery, and quality of life
Euromed Alliance
(formerly Euromed Prestige)
Our medical team integrates LASMIK® Low-Level Laser Therapy into individualized supportive-care and rehabilitation protocols based on patient needs and clinical indications.
📞 +1 (619) 901-5041📧 info@euromedalliance.com
Comments